Cytokine conjugation to enhance T cell therapy

Adoptive T cell transfer (ACT) therapies suffer from a number of limitations (e.g., poor control of solid tumors), and while combining ACT with cytokine therapy can enhance effectiveness, this also results in significant side effects. Here, we describe a nanotechnology approach to improve the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yutong, Adu-Berchie, Kwasi, Brockman, Joshua M., Pezone, Matthew, Zhang, David K.Y., Zhou, Jingyi, Pyrdol, Jason W., Wang, Hua, Wucherpfennig, Kai W., Mooney, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910457/
https://www.ncbi.nlm.nih.gov/pubmed/36577059
http://dx.doi.org/10.1073/pnas.2213222120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910457/
https://www.ncbi.nlm.nih.gov/pubmed/36577059
http://dx.doi.org/10.1073/pnas.2213222120

Ejemplares similares